We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
(+3.2%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$67.7M |
| 2 |
Corteva
CTVA
|
+$33.4M |
| 3 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$19.3M |
| 4 |
Spotify
SPOT
|
+$15.3M |
| 5 |
Amcor
AMCR
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$62.6M |
| 2 |
Apple
AAPL
|
+$51.5M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$29.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 15.55% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Elastic
ESTC
$6.84B
| $2.62M | ﹤0.01% |
35,094
+27,196
| +344% | +$2.22M |
|
|
ICPT
1577
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.61M | ﹤0.01% |
32,764
+3,850
| +13% | +$345K |
|
1578
First Hawaiian
FHB
$3.38B
| $2.6M | ﹤0.01% |
100,511
+3,500
| +4% | +$92.6K |
|
1579
Central Pacific Financial
CPF
$1.02B
| $2.6M | ﹤0.01% |
86,735
+1,772
| +2% | +$51.7K |
|
|
NTUS
1580
DELISTED
Natus Medical Inc
NTUS
| $2.6M | ﹤0.01% |
101,065
+5,056
| +5% | +$129K |
|
1581
Corcept Therapeutics
CORT
$12.4B
| $2.59M | ﹤0.01% |
232,604
+4,416
| +2% | +$49.2K |
|
|
TSE
1582
DELISTED
Trinseo
TSE
| $2.59M | ﹤0.01% |
61,238
+2,403
| +4% | +$103K |
|
|
WW
1583
DELISTED
WW International
WW
| $2.59M | ﹤0.01% |
135,422
+16,871
| +14% | +$334K |
|
1584
Builders FirstSource
BLDR
$7.15B
| $2.59M | ﹤0.01% |
153,401
+3,879
| +3% | +$58K |
|
1585
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
| $2.59M | ﹤0.01% |
91,770
+6,212
| +7% | +$165K |
|
1586
Scansource
SCSC
$1.15B
| $2.57M | ﹤0.01% |
78,911
+2,661
| +3% | +$90.4K |
|
|
PGRE
1587
DELISTED
Paramount Group
PGRE
| $2.56M | ﹤0.01% |
183,060
-408
| -0.2% | -$5.88K |
|
1588
Pathward Financial
CASH
$1.86B
| $2.56M | ﹤0.01% |
91,175
+13,554
| +17% | +$345K |
|
|
NRE
1589
DELISTED
NorthStar Realty Europe Corp.
NRE
| $2.56M | ﹤0.01% |
155,480
+6,050
| +4% | +$102K |
|
1590
Invesco S&P 500 Equal Weight ETF
RSP
$97B
| $2.55M | ﹤0.01% |
23,694
+4,108
| +21% | +$435K |
|
1591
Kelly Services Class A
KELYA
$514M
| $2.55M | ﹤0.01% |
97,325
+4,608
| +5% | +$110K |
|
1592
Golar LNG
GLNG
$5B
| $2.55M | ﹤0.01% |
137,785
+1,327
| +1% | +$25.2K |
|
1593
MGP Ingredients
MGPI
$379M
| $2.53M | ﹤0.01% |
38,154
+1,306
| +4% | +$92K |
|
1594
Pacira BioSciences
PCRX
$1.04B
| $2.53M | ﹤0.01% |
58,152
+3,627
| +7% | +$154K |
|
1595
CorVel
CRVL
$3.06B
| $2.52M | ﹤0.01% |
87,060
+1,890
| +2% | +$46.5K |
|
1596
Virtus Investment Partners
VRTS
$1.06B
| $2.52M | ﹤0.01% |
23,434
+240
| +1% | +$26.8K |
|
1597
Onto Innovation
ONTO
$12.9B
| $2.52M | ﹤0.01% |
72,467
+4,895
| +7% | +$156K |
|
1598
M/I Homes
MHO
$3.74B
| $2.51M | ﹤0.01% |
88,049
+2,663
| +3% | +$75.1K |
|
1599
Bankunited
BKU
$3.37B
| $2.51M | ﹤0.01% |
74,401
-4,908
| -6% | -$169K |
|
|
PTLA
1600
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.51M | ﹤0.01% |
92,437
+5,442
| +6% | +$171K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
- RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
- RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
- RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
- RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
- RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.